During the past decade, InnoDiab Forschung Gmbh conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 8 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 6 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "InnoDiab Forschung Gmbh" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Bayer" with 3 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "KBP Biosciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "InnoDiab Forschung Gmbh" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "InnoDiab Forschung Gmbh" are "Type 2 Diabetes" (6 trials), "Diabetes Mellitus, Type 1" (3 trials), "Chronic Kidney Disease" (2 trials), "Neuropathic Pain Associated With Diabetic Peripheral Neuropathy" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "InnoDiab Forschung Gmbh" in a lesser frequency.

Most popular intervention types in "InnoDiab Forschung Gmbh" are "Drug" (20 trials), "Other" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Tirzepatide" (7 trials), "Insulin Degludec" (4 trials), "Dulaglutide" (2 trials) and "Empagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "InnoDiab Forschung Gmbh" are 22 trials for "All" genders.

Currently, there are NaN active trials in "InnoDiab Forschung Gmbh". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in InnoDiab Forschung Gmbh, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in InnoDiab Forschung Gmbh, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".